SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-010080
Filing Date
2022-05-16
Accepted
2022-05-16 16:14:49
Documents
81
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dna-20220331.htm   iXBRL 10-Q 3455767
2 EX-31.1 dna-ex31_1.htm EX-31.1 19802
3 EX-31.2 dna-ex31_2.htm EX-31.2 19210
4 EX-32.1 dna-ex32_1.htm EX-32.1 11203
5 EX-32.2 dna-ex32_2.htm EX-32.2 11687
  Complete submission text file 0000950170-22-010080.txt   13305906

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20220331_def.xml EX-101.DEF 388850
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dna-20220331_cal.xml EX-101.CAL 53899
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20220331.xsd EX-101.SCH 73653
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20220331_lab.xml EX-101.LAB 625750
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20220331_pre.xml EX-101.PRE 517697
75 EXTRACTED XBRL INSTANCE DOCUMENT dna-20220331_htm.xml XML 2862936
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40097 | Film No.: 22929188
SIC: 2836 Biological Products, (No Diagnostic Substances)